Inovio Pharmaceuticals (INO) Share-based Compensation (2010 - 2026)
Inovio Pharmaceuticals (INO) recorded Share-based Compensation of $768,437 in Q2 2026, down 7.9% from $834,792 a year earlier but up 10.0% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Share-based Compensation (2010 - 2026) Analysis & Trends
On a TTM basis, Inovio Pharmaceuticals' Share-based Compensation came in at $2.99 million as of Jun 30, 2026, down 37.6% year-over-year; for FY2025, it was $3.76 million, down 43.1% from FY2024.
- Annual Share-based Compensation has declined for four straight years, with a five-year compound annual growth rate of -24.8% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $6.6 million in FY2024 (-40.4%), $11.07 million in FY2023 (-50.9%), $22.56 million in FY2022 (-14.4%) and $26.34 million in FY2021 (+68.3%).
- Quarterly Share-based Compensation has ranged from $698,744 in Q1 2026 to $8.34 million in Q2 2022 over the past five years.
- On a year-over-year basis, Share-based Compensation has declined for 16 consecutive quarters, with an average decline of 38.8% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 47.6% in Q2 2022, against a decline of 65.0% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $698,744 (Q1 2026), $764,561 (Q4 2025) and $757,086 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Inovio Pharmaceuticals | 68.68 Mn | -114.99 Mn | - | 768,437.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 768,437.00 |
| Mar 31, 2026 | 698,744.00 |
| Dec 31, 2025 | 764,561.00 |
| Sep 30, 2025 | 757,086.00 |
| Jun 30, 2025 | 834,792.00 |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Dec 31, 2023 | 2.27 Mn |
| Sep 30, 2023 | 2.08 Mn |
| Jun 30, 2023 | 2.92 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Dec 31, 2022 | 3.27 Mn |
| Sep 30, 2022 | 3.23 Mn |
| Jun 30, 2022 | 8.34 Mn |
| Mar 31, 2022 | 7.71 Mn |
| Dec 31, 2021 | 5.47 Mn |
| Sep 30, 2021 | 5.62 Mn |
API Access
Inovio Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();